Jessilin Quint, OD, MS, MBA, FAAO
Show Description +
Jessilin Quint, OD, MS, MBA, FAAO, highlights the benefits of Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% (Orasis Pharmaceuticals Inc.) and how it can enhance the eye’s accommodative ability by targeting the biomechanical properties of the lens. She explains how this presbyopia drop can improve near vision without compromising distance.
Posted: 7/30/2025
Jessilin Quint, OD, MS, MBA, FAAO
Jessilin Quint, OD, MS, MBA, FAAO, highlights the benefits of Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% (Orasis Pharmaceuticals Inc.) and how it can enhance the eye’s accommodative ability by targeting the biomechanical properties of the lens. She explains how this presbyopia drop can improve near vision without compromising distance.
Posted: 7/30/2025
About Orasis Pharmaceuticals
ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.
The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.
Visit us online: orasis-pharma.com
Follow Orasis Pharmaceuticals